本页面由Tiger Trade Technology Pte. Ltd.提供服务

CALIDI BIOTHERAPEUTICS INC

0.9499
-0.0801-7.78%
盘前:0.9390-0.0109-1.15%06:56 EDT
成交量:5.30万
成交额:5.13万
市值:350.11万
市盈率:-0.03
高:0.9980
开:0.9980
低:0.9371
收:1.03
52周最高:27.84
52周最低:0.9371
股本:368.58万
流通股本:365.71万
量比:1.48
换手率:1.45%
股息:- -
股息率:- -
每股收益(TTM):-33.3374
每股收益(LYR):-95.1334
净资产收益率:-672.22%
总资产收益率:-134.79%
市净率:1.12
市盈率(LYR):-0.01

数据加载中...

2024/04/01

重要事件披露

Form 8-K - Current report
2024/04/01

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/03/18

重要事件披露

Form 8-K - Current report
2024/03/15

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/12

重要事件披露

Form 8-K - Current report
2024/03/01

重要事件披露

Form 8-K - Current report
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

重要事件披露

Form 8-K - Current report
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

重要事件披露

Form 8-K - Current report
2024/02/07

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/02/01

重要事件披露

Form 8-K - Current report
2024/01/29

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/01/17

SEC问询函

Form CORRESP - Correspondence
2024/01/16

SEC问询函

Form CORRESP - Correspondence
2024/01/16

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]